1,414
Participants
Start Date
November 29, 2023
Primary Completion Date
May 30, 2025
Study Completion Date
May 30, 2025
Zavegepant
The participants will receive single active dose sufficient to treat 1 migraine headache of moderate or severe intensity within Treatment Phase.
Placebo
Single dose of matching placebo taken within Treatment Phase.
Chang Gung Medical Foundation-Linkou Branch, Taoyuan District
Inje University - Ilsan Paik Hospital, Goyang-si
Taipei Veterans General Hospital, Taipei
Tri-Service General Hospital, Taipei
The Catholic University of Korea, Uijeongbu St. Mary's Hospital, Uijeongbu-si
Seoul National University Bundang Hospital, Seongnam-si
Seoul National University Bundang Hospital, Seongnam
Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si
Dong-A University Hospital, Busan
Peking University People's Hospital, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Xuanwu Hospital Capital Medical University, Beijing
The First Medical Center of Chinese PLA General Hospital, Beijing
The People's Hospital of Liaoning Province, Shenyang
The First Hospital of Jilin University, Changchun
Huashan Hospital, Fudan University, Shanghai
Shanghai East Hospital, Shanghai
Shanghai East Hospital, Shanghai
The Second Affiliated Hospital of Nanjing Medical University, Nanjing
The Affiliated Hospital of Jiangsu University, Zhenjiang
Wuxi People's Hospital, Wuxi
Affiliated Hospital of Jiangnan University, Wuxi
The Second Affiliated Hospital of Soochow University, Suzhou
The Second People's Hospital of Lianyungang, Lianyungang
The Second People's hospital of Hefei, Hefei
Qilu Hospital of Shandong University, Jinan
Jinan Central Hospital, Jinan
Liaocheng people's Hospital, Liaocheng
Qingdao Central Hospital, Qingdao
Affiliated Hospital of Jining Medical University, Jining
People's Hospital of Rizhao, Rizhao
Tianjin Union Medical Center, Tianjin
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou
The First Affiliated Hosptial of Wenzhou Medical University, Wenzhou
Ruian People's Hospital, Rui’an
Pingxiang People's Hospital, Pingxiang
The First Affiliated Hospital of Chongqing Medical University, Chongqing
Chongqing University Three Gorges Hospital, Chongqing
Changsha Central Hospital, Changsha
The Third Xiangya Hospital of Central South University, Changsha
Renmin Hospital Of Wuhan University, Wuhan
Wuhan Third Hospital, Wuhan
People's Hospital of Zhengzhou, Zhengzhou
The First Affiliated Hospital of Henan University of Science &Technology, Luoyang
The First Affiliated Hospital of Henan University of Science &Technology, Luoyang
Hainan General Hospital, Haikou
First Affiliated Hospital of Kunming Medical University, Kunming
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Shaanxi Provincial People' Hospital, Xi'an
Xian Gaoxin Hospital, Xi'an
Xianyang Hospital of Yan'an University, Xianyang
The First People's Hospital of Yinchuan, Yinchuan
General Hospital of Ningxia Medical Hospital, Yinchuan
Heping Hospital Affiliated to Changzhi Medical College, Changzhi
The fourth people's hospital of chongqing, Chongqing
Nowon Eulji Medical Center, Eulji University, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Ewha Womans University Seoul Hospital, Seoul
Kangbuk Samsung Hospital, Seoul
Lead Sponsor
Pfizer
INDUSTRY